COFEPRIS
- Status: likely_approved
Drospirenone Ethinyl estradiol (Drospirenone Ethinyl estradiol) regulatory status in Mexico.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. COFEPRIS has authorised it.
AGUNCO Obstetrics and Gynecology Centre is the originator. The local marketing authorisation holder may differ — check the official source linked above.